Founding Organizations:
Home
About Us
Faculty
KOL Conversations
Podcasts
Symposium Vignettes
Archived Symposium
AI Digital Library
AI Management Tools
Live Events
Subscribe
X
Full Name
Email Address
Provider Type
Select Category
MD
DO
PA
NP
RN
MA
Dietician
Other
This field is required
Subscribe
Reset
Search by categories:
Podcasts
KOL Conversations
Symposium Vignettes
AI Digital Library
AI Management Tools
Podcast
Category
Symposium Vignettes
KOL Conversation
Podcast
Sort by
Oldest
Newest
Part 1 - Incorporating the Newly Approved Therapy for MASH into Practice
Part 2 - Using NITs to Identify and Manage MASH Patients
Part 3 - Strategies for Educating the APP Community on MASH
Part 4 - MASH- What We Don't Know, What We Want to Know
Key Takeaways - Major Advancements In The Management of MASH with Parvez, Mantry, MD
GHAPPcast: Recognizing the Severity of MASH
What is MASH?
How Is MASH Severity Staged? What Would an Ideal MASH NIT Algorithm Look Like?
What Are the Consequences of MASH Going Untreated?
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
What Is the Clinical Profile of Resmetirom, Including Dosing Schedules?
What Is Resmetirom and How Does It Work to Treat MASH?
